Werewolf Therapeutics
About:
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Website: https://werewolftx.com/
Twitter/X: werewolfthera
Top Investors: RA Capital Management, Deerfield, Longwood Fund, Soleus Capital, MPM Capital
Description:
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
Total Funding Amount:
$178M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)werewolftx.com
Founders:
Dan Hicklin
Number of Employees:
11-50
Last Funding Date:
2022-05-10
IPO Status:
Public
Industries:
© 2025 bioDAO.ai